NFKB1 and breast carcinoma: To test the direct transcriptional effects of RelA/NF-κB signaling in ER+ breast cancer in HD conditions, we integrated the RelA ChIP-seq (binding sites in HD conditions) and RNA-seq (differential expression between HD and E2 conditions), using the BETA algorithm (41).